![Albert Dyrness](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert Dyrness
Fondateur chez
ADVENT Engineering Services, Inc.
Fortune : 10 805 $ au 31/08/2026
Profil
Mr. Albert D.
Dyrness is an Independent Director at Hyperliquid Strategies, Inc., a Managing Director & Vice President at ADVENT Engineering Services, Inc. and a Vice Chairman-Bioprocess Equipment Standard at American Society of Mechanical Engineers.
He is on the Board of Directors at Hyperliquid Strategies, Inc. and Sonnet BioTherapeutics, Inc. Mr. Dyrness was previously employed as an Independent Director by Sonnet BioTherapeutics Holdings, Inc. and an Independent Director by Oncobiologics, Inc. He received his undergraduate degree from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0% | 09/02/2026 | 882 ( 0% ) | 10 805 $ | 31/08/2026 |
Postes actifs de Albert Dyrness
| Sociétés | Poste | Début |
|---|---|---|
American Society of Mechanical Engineers
 American Society of Mechanical Engineers Miscellaneous Commercial ServicesCommercial Services Operates non-profit professional organization that enables collaboration, knowledge sharing and skill development for engineering community | Corporate Officer/Principal | - |
ADVENT Engineering Services, Inc.
 ADVENT Engineering Services, Inc. Engineering & ConstructionIndustrial Services Provides superior nuclear power, research and specialty engineering services. | Fondateur | 01/01/1988 |
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Directeur/Membre du Conseil | 01/10/2019 |
Anciens postes connus de Albert Dyrness
| Sociétés | Poste | Fin |
|---|---|---|
| SONNET BIOTHERAPEUTICS | Directeur/Membre du Conseil | 02/12/2025 |
| OUTLOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2017 |
Formation de Albert Dyrness
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
American Society of Mechanical Engineers
American Society of Mechanical Engineers Miscellaneous Commercial ServicesCommercial Services Operates non-profit professional organization that enables collaboration, knowledge sharing and skill development for engineering community | Commercial Services |
ADVENT Engineering Services, Inc.
ADVENT Engineering Services, Inc. Engineering & ConstructionIndustrial Services Provides superior nuclear power, research and specialty engineering services. | Industrial Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Sonnet BioTherapeutics Holdings, Inc.
 Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
